We analyzed the relationship between tumor‐infiltrating immune cells (CD4, CD8, FOXP3, CD163‐positive cells) and proteins (TGFβ1 and its downstream signal, SMAD3) expression and survival after the start of combined therapy with immune checkpoint inhibitors plus chemotherapy in SCLC. This evidence concerns the gene CD4 and neoplasm.